Visualization on SMAC-25m based on <i>LazyAct</i>. by Hongjie Zhang (136127)

Single agent and multi-agents tasks for <i>LazyAct</i>. by Hongjie Zhang (136127)

Network architectures for multi-agents task. by Hongjie Zhang (136127)

Expression of HCP-1 and HIF-1α in RGK36 cells. HCP-1, HIF-1α, and β-actin were detected by western blot. by Hiromi Kurokawa (7377806)

Analysis of c-Kit immunohistochemistry. by Yong Hwan Kwon (3612245)

S1 Raw data - by Yongle Du (3992198)

“…Metabonomic analysis revealed significant changes in 13 serum metabolites, with ZJP reversing the expression of 5 key metabolites. By integrating metabonomics with network pharmacology, we identified core targets of ZJP against myopia and constructed a compound-gene-disease-metabolite network. …”

Primer sequences for target genes. by Yongle Du (3992198)

“…Metabonomic analysis revealed significant changes in 13 serum metabolites, with ZJP reversing the expression of 5 key metabolites. By integrating metabonomics with network pharmacology, we identified core targets of ZJP against myopia and constructed a compound-gene-disease-metabolite network. …”

A Meta-Analysis of Anti-Vascular Endothelial Growth Factor Remedy for Macular Edema Secondary to Central Retinal Vein Occlusion by Peirong Huang (501361)

“…</p><p>Methods</p><p>Data were collected and analyzed by Review Manager 5.2.1. We employed a random-effects model to eliminate between-study heterogeneity. …”

Data_Sheet_1_Nationwide Initiation of Cardiovascular Risk Treatments During the COVID-19 Pandemic in France: Women on a Slippery Slope?.DOCX by Amélie Gabet (12451977)

“…</p>Results<p>In 2020, IRR significantly decreased for initiations of antihypertensives (−11.1%[CI95%, −11.4%;−10.8%]), lipid-lowering drugs (−5.2%[CI95%, −5.5%;−4.8%]), oral anticoagulants in atrial fibrillation (−8.6%[CI95%, −9.1%;−8.0%]), and smoking cessation medications (−50.9%[CI95%, −51.1%;−50.7%]) compared to 2017–2019. …”

Effects of acalabrutinib inhibitors on canine lymphoma cells. by Bonnie K. Harrington (3151176)

“…Dose-dependent reductions in cell proliferation following daily treatment with acalabrutinib in the canine CLBL1 B-cell lymphoma cell line. Results are the mean of 5 independent experiments. Raw data were log transformed to reduce variance and skewness. …”

Improving socioeconomic status may reduce the burden of malaria in sub Saharan Africa: A systematic review and meta-analysis by Abraham Degarege (641120)

“…The odds of <i>Plasmodium</i> infection also increased with a decrease in the income (OR 1.02, 95% CI 1.01–1.03, tau²<0.001), and wealth index of individuals (OR 1.25, 95% CI 1.18–1.35, tau² = 0.028) [p<0.001 for both]. …”

Image_9_Inhibition of Cronobacter sakazakii in an infant simulator of the human intestinal microbial ecosystem using a potential synbiotic.JPEG by Alfred Ke (13049280)

Image_7_Inhibition of Cronobacter sakazakii in an infant simulator of the human intestinal microbial ecosystem using a potential synbiotic.JPEG by Alfred Ke (13049280)

Image_8_Inhibition of Cronobacter sakazakii in an infant simulator of the human intestinal microbial ecosystem using a potential synbiotic.JPEG by Alfred Ke (13049280)

Loss of NK cell activation receptor expression following tumor-priming. by May Sabry (6883232)

“…The percentage change of NK cell expression was calculated for each receptor after stimulation and results are presented as the mean of 3–5 different donors. Red indicates an increase, and green indicates a decrease in receptor expression, according to the key on the right, relative to NK cells in medium alone. …”

Table_1_Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.DOCX by Prajwal Boddu (5780843)

“…Three and one complete responses were observed at dose-levels “0” and “1,” respectively; the overall response rate (ORR) was 36% (4 of 11 patients). A ≥ 50% decrease in CXCR4 mean fluorescence intensity was observed in 4 of 9 patients by flow cytometry, indicating incomplete suppression of CXCR4-receptor occupancy.…”

Table_1_Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.DOCX by Prajwal Boddu (5780843)

“…Three and one complete responses were observed at dose-levels “0” and “1,” respectively; the overall response rate (ORR) was 36% (4 of 11 patients). A ≥ 50% decrease in CXCR4 mean fluorescence intensity was observed in 4 of 9 patients by flow cytometry, indicating incomplete suppression of CXCR4-receptor occupancy.…”

Different dynamics in counter-FF and co-FF cells under L-rate and H-rate as a function of trial number. by Yael Mandelblat-Cerf (348508)

Progeny production per day. by Jennifer M. Gleason (18251147)

Validation of the optimum formula. by Randa Mohammed Zaki (21637175)

“…EE%, VS, and ZP were predicted to be 88.4977%, 594.592 nm, and −44.2354 mV, respectively. The validation process on the optimized formula demonstrated that the variation from the predicted responses was less than 5%. …”